Briefing Information for the June 29-30, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee

  FDA

Disclaimer

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).

FDA Briefing Material 

Options Paper and Memo (pdf)
Working Group Report (pdf) 
Addendum (pdf)

Rocky Mountain Poison and Drug Center

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Rocky Mountain Poison and Drug Center Briefing Material (pdf)

Consumer Healthcare Products Association

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Consumer Healthcare Products Association (pdf)

Johnson & Johnson Pharmaceutical Research & Development, L.L.C

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C (pdf)

Addendum (pdf)

McNeil Consumer Health Care

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

McNeil Consumer Health Care (pdf)